Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Brander who wrote (23013)	10/23/2000 3:39:33 AM
From: Patscara	Read Replies (1) \| Respond to of 23519

Bander, You are right in that every one thought that FDA approval on Alibra was a slam-dunk, including me! We will not know what the problem is until Vivus tells us and my only fear is that they won't. This has already raised many questions about Alista and the company has got a another big hill to climb, especially with the perception about the company itself. Vivus had better do some serious ass kissing to its shareholders And put out some serious PR about everything positive it has Going for it self. We will see what tomorrow brings. Hopefully, they will shed Some light on the withdrawal.